FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages
Aleah R. Hunt, Shawn N. Coffeen, View ORCID ProfileDane L. Shiltz, View ORCID ProfileCalvin Ice, Jessica Parker
doi: https://doi.org/10.1101/2020.08.19.20178061
Aleah R. Hunt
Spectrum Health Butterworth Hospital;
PharmDShawn N. Coffeen
PharmD
Dane L. Shiltz
PharmD, BCPS
Calvin Ice
PharmD, BCPS, BCCPS
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data included in the manuscript has been deidentified and retained on an internal redCAP database.
Posted August 25, 2020.
FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages
Aleah R. Hunt, Shawn N. Coffeen, Dane L. Shiltz, Calvin Ice, Jessica Parker
medRxiv 2020.08.19.20178061; doi: https://doi.org/10.1101/2020.08.19.20178061
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (653)
- Anesthesia (174)
- Cardiovascular Medicine (2541)
- Dermatology (212)
- Emergency Medicine (387)
- Epidemiology (12014)
- Forensic Medicine (10)
- Gastroenterology (724)
- Genetic and Genomic Medicine (3934)
- Geriatric Medicine (369)
- Health Economics (658)
- Health Informatics (2538)
- Health Policy (979)
- Hematology (353)
- HIV/AIDS (816)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3695)
- Nursing (205)
- Nutrition (549)
- Oncology (1921)
- Ophthalmology (560)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1081)
- Primary Care Research (436)
- Public and Global Health (6366)
- Radiology and Imaging (1344)
- Respiratory Medicine (849)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (159)